Nomura Holdings Inc Neurocrine Biosciences Inc Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nomura Holdings Inc holds 11,500 shares of NBIX stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,500

Previous 1,700 576.47%

Holding current value

$1.44 Million

Previous $234,000 465.38%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $222,462 - $243,423	1,700 New	1,700 $234,000
Q3 2022 Nov 15, 2022	BUY	$92.03 - $107.81 $828,270 - $970,290	9,000 New	9,000 $956,000
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $358,425 - $477,990	4,500 New	4,500 $383,000
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $1.07 Million - $1.23 Million	-12,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $1.05 Million - $1.43 Million	12,000 New	12,000 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $3.3 Million - $4.12 Million	-38,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $2.81 Million - $3.95 Million	29,229 Added 333.25%	38,000 $3.65 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $658,789 - $997,788	8,771 New	8,771 $761,000
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $642,415 - $972,989	-8,553 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $1.9 Million - $2.6 Million	-21,947 Reduced 71.96%	8,553 $919,000
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $2.26 Million - $2.74 Million	27,000 Added 771.43%	30,500 $2.73 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $3.91 Million - $4.94 Million	-54,168 Reduced 93.93%	3,500 $297,000
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $554,341 - $732,056	-7,998 Reduced 12.18%	57,668 $5.12 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $647,605 - $1.18 Million	9,479 Added 16.87%	65,666 $4.68 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $1.7 Million - $2.16 Million	17,148 Added 43.93%	56,187 $6.99 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $168,897 - $237,735	-2,243 Reduced 5.43%	39,039 $2.98 Million
Q1 2018 May 14, 2018	SELL	$75.88 - $92.43 $1.21 Million - $1.47 Million	-15,882 Reduced 27.78%	41,282 $3.42 Million
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $3.13 Million - $3.82 Million	41,282 Added 259.93%	57,164 $4.66 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $936,480 - $1.24 Million	-16,000 Reduced 50.19%	15,882 $1.23 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $1.53 Million - $1.95 Million	31,882	31,882 $1.95 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Neurocrine Biosciences Inc Transaction History